Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesia Effects on MRD in Colon Cancer Surgery
NCT02314871Phase 4Completed
- Sponsor
- Institute of Molecular and Translational Medicine
- Start
- Jan 2015
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, sufentanil, piritramide in colon cancer, sponsored by Institute of Molecular and Translational Medicine. Started Jan 2015; status: completed.
02
Drugs
bupivacainesufentanilpiritramide
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02314871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314871.